molephantinin

germacranolide from Elephantopus mollis; RN given refers to (3aR-(3aR*,4S*(E),6E,9Z,11S*,11aS*))-isomer; structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Carcinoma (Carcinomatosis) 06/01/1982 - "The principle effect of molephantinin on Ehrlich ascites carcinoma cells was to depress DNA and protein synthesis both in vivo and in vitro. " 09/01/1980 - "Preliminary in vivo tumor assays indicated that molephantinin and phantomolin were potent inhibitors of Ehrlich ascites carcinoma and Walker 256 carcinosarcoma. "
2.	Ascites 06/01/1982 - "The principle effect of molephantinin on Ehrlich ascites carcinoma cells was to depress DNA and protein synthesis both in vivo and in vitro. " 09/01/1980 - "Preliminary in vivo tumor assays indicated that molephantinin and phantomolin were potent inhibitors of Ehrlich ascites carcinoma and Walker 256 carcinosarcoma. " 06/01/1982 - "Antitumor agents LII: The effects of molephantinin on nucleic acid and protein synthesis of Ehrlich ascites cells."
3.	Neoplasms (Cancer) 09/01/1980 - "Preliminary in vivo tumor assays indicated that molephantinin and phantomolin were potent inhibitors of Ehrlich ascites carcinoma and Walker 256 carcinosarcoma. "
4.	Lymphoid Leukemia 09/01/1980 - "Molephantinin also showed significant antileukemic activity in the P-388 lymphocytic leukemia screen."
5.	Carcinosarcoma 09/01/1980 - "Preliminary in vivo tumor assays indicated that molephantinin and phantomolin were potent inhibitors of Ehrlich ascites carcinoma and Walker 256 carcinosarcoma. "

1.	Proteins (Proteins, Gene)
2.	Nucleic Acids
3.	DNA (Deoxyribonucleic Acid)
4.	Antineoplastic Agents (Antineoplastics)
5.	phantomolin